Molekulargenetik bei „premature ovarian insufficiency“: von der Störung der Follikulogenese bis zur POI
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Deutsch
- Bibliographic citation
-
Molekulargenetik bei „premature ovarian insufficiency“: von der Störung der Follikulogenese bis zur POI ; volume:27 ; number:2 ; day:23 ; month:5 ; year:2024 ; pages:80-86 ; date:6.2024
Journal für gynäkologische Endokrinologie ; 27, Heft 2 (23.5.2024), 80-86, 6.2024
- Keyword
-
Gynäkologische Endokrinologie
Molekulargenetik
- Creator
-
Rehnitz, Julia
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s41975-024-00348-9
- URN
-
urn:nbn:de:101:1-2408191007504.244937146786
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rehnitz, Julia
- SpringerLink (Online service)
Other Objects (12)
The need to identify novel biomarkers for prediction of premature ovarian insufficiency (POI)
Plasma metabolomic characterization of premature ovarian insufficiency
Rare variants in FANCA induce premature ovarian insufficiency
Association of Coenzyme Q10 with Premature Ovarian Insufficiency
Role of microRNAs in premature ovarian insufficiency
Association between premature ovarian insufficiency and gut microbiota
Depletion of placental brain-derived neurotrophic factor (BDNF) is attributed to premature ovarian insufficiency (POI) in mice offspring
Oligogenic basis of premature ovarian insufficiency: an observational study
Premature ovarian insufficiency: the context of long-term effects
Genetic insights into the complexity of premature ovarian insufficiency
Therapeutic options for premature ovarian insufficiency: an updated review
BCAA insufficiency leads to premature ovarian insufficiency via ceramide‐induced elevation of ROS
The need to identify novel biomarkers for prediction of premature ovarian insufficiency (POI)
Plasma metabolomic characterization of premature ovarian insufficiency
Rare variants in FANCA induce premature ovarian insufficiency
Association of Coenzyme Q10 with Premature Ovarian Insufficiency
Role of microRNAs in premature ovarian insufficiency
Association between premature ovarian insufficiency and gut microbiota
Depletion of placental brain-derived neurotrophic factor (BDNF) is attributed to premature ovarian insufficiency (POI) in mice offspring
Oligogenic basis of premature ovarian insufficiency: an observational study
Premature ovarian insufficiency: the context of long-term effects
Genetic insights into the complexity of premature ovarian insufficiency
Therapeutic options for premature ovarian insufficiency: an updated review
BCAA insufficiency leads to premature ovarian insufficiency via ceramide‐induced elevation of ROS
The need to identify novel biomarkers for prediction of premature ovarian insufficiency (POI)
Plasma metabolomic characterization of premature ovarian insufficiency
Rare variants in FANCA induce premature ovarian insufficiency
Association of Coenzyme Q10 with Premature Ovarian Insufficiency
Role of microRNAs in premature ovarian insufficiency
Association between premature ovarian insufficiency and gut microbiota
Depletion of placental brain-derived neurotrophic factor (BDNF) is attributed to premature ovarian insufficiency (POI) in mice offspring
Oligogenic basis of premature ovarian insufficiency: an observational study
Premature ovarian insufficiency: the context of long-term effects
Genetic insights into the complexity of premature ovarian insufficiency
Therapeutic options for premature ovarian insufficiency: an updated review